Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.

PubMed  Article  Google Scholar 

Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–7.

PubMed  Article  Google Scholar 

Plichta DR, Graham DB, Subramanian S, Xavier RJ. Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships. Cell. 2019;178(5):1041–56.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39–49.

PubMed  Article  Google Scholar 

Al Nabhani Z, Dulauroy S, Marques R, Cousu C, Al Bounny S, Déjardin F, et al. A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity. 2019;50(5):1276–88.

CAS  PubMed  Article  Google Scholar 

Borbet TC, Blaser MJ. Host genotype and early life microbiota alterations have additive effects on disease susceptibility. Mucosal Immunol. 2019;12(3):586–8.

CAS  PubMed  Article  Google Scholar 

Fachi JL, Felipe JS, Pral LP, da Silva BK, Corrêa RO, de Andrade MCP, et al. Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism. Cell Rep. 2019;27(3):750–61.

CAS  PubMed  Article  Google Scholar 

Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, et al. Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology. Nat Rev Gastroenterol Hepatol. 2019;26(10):2704–19.

CAS  Google Scholar 

Schirmer M, Garner A, Vlamakis H, Xavier RJ, et al. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17(8):497–511.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zuo T, Lu XJ, Zhang Y, Cheung CP, Lam S, Zhang F, et al. Gut mucosal virome alterations in ulcerative colitis. Gut. 2019;68(7):1169–79.

CAS  PubMed  Article  Google Scholar 

Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160(3):447–60.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ungaro F, Massimino L, D’Alessio S, Danese S. The gut virome in inflammatory bowel disease pathogenesis: from metagenomics to novel therapeutic approaches. United Eur Gastroenterol J. 2019;7(8):999–1007. https://doi.org/10.1177/2050640619876787.

CAS  Article  Google Scholar 

Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013;6(3):498–510.

CAS  PubMed  Article  Google Scholar 

Nakanishi Y, Sato T, Ohteki T, et al. Commensal gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization. Nat Rev Gastroenterol Mucosal Immunol. 2015;8(1):152–60.

CAS  Article  Google Scholar 

Giles EM, Sanders TJ, McCarthy NE, Lung J, Pathak M, MacDonald TT, et al. Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease. Mucosal Immunol. 2017;10(1):184–93.

CAS  PubMed  Article  Google Scholar 

Bernardo D, Marin AC, Fernández-Tomé S, Montalban-Arques A, Carrasco A, Tristán E, et al. Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease. Mucosal Immunol. 2018;11(4):1114–26.

CAS  PubMed  Article  Google Scholar 

Na YR, Stakenborg M, Seok SH, Matteoli G, et al. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531–43.

CAS  PubMed  Article  Google Scholar 

Eftychi C, Schwarzer R, Vlantis K, Wachsmuth L, Basic M, Wagle P, et al. Temporally distinct functions of the cytokines IL-12 and IL-23 drive chronic colon inflammation in response to intestinal barrier impairment. Immunity. 2019;51(2):367–80.

CAS  PubMed  Article  Google Scholar 

Rauch I, Müller M, Decker T. The regulation of inflammation by interferons and their STATs. JAK-STAT. 2013;2(1):e23820.

PubMed  PubMed Central  Article  Google Scholar 

Decker T, Stockinger S, Karaghiosoff M, Müller M, Kovarik P. IFNs and STATs in innate immunity to microorganisms. J Clin Investig. 2002;109(10):1271–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ivashkiv LB. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545–58.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Berry D, Schwab C, Milinovich G, Reichert J, Ben Mahfoudh K, Decker T, et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J. 2012;6(11):2091–106.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Crnčec I, Modak M, Gordziel C, Svinka J, Scharf I, Moritsch S, et al. STAT1 is a sex-specific tumor suppressor in colitis-associated colorectal cancer. Mol Oncol. 2018;12(4):514–28.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Kang YH, Biswasx A, Field M, Snapper SB. STAT1 signaling shields T cells from NK cell-mediated cytotoxicity. Nat Commun. 2019;10(1):912.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Nakanishi Y, Sato T, Takahashi K, Ohteki T, et al. IFN-γ-dependent epigenetic regulation instructs colitogenic monocyte/macrophage lineage differentiation in vivo. Mucosal Immunol. 2018;11(3):871–80.

CAS  PubMed  Article  Google Scholar 

Wu X, Guo W, Wu L, Gu Y, Gu L, Xu S, et al. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J Immunol. 2012;189(7):3497–507.

CAS  PubMed  Article  Google Scholar 

Bandyopadhyay SK, de la Motte CA, Kessler SP, Hascall VC, Hill DR, Strong SA, et al. Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1. Am J Pathol. 2008;173(5):1361–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A, et al. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut. 2002;51(3):379–85.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kitamura H, et al. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity. 2005;23(5):491–502.

CAS  PubMed  Article  Google Scholar 

Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694–702.

CAS  PubMed  Article  Google Scholar 

Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114(3):385–91.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ohno Y, Kitamura H, Takahashi N, Ohtake J, Kaneumi S, Sumida K, et al. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells. Cancer Immunol Immunother. 2016;65(2):193–204.

CAS  PubMed  Article  Google Scholar 

Ohno Y, Toyoshima Y, Yurino H, Monma N, Xiang H, Sumida K, et al. Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy. Cancer Sci. 2017;108(10):1959–66.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kitamura H, Ohno Y, Toyoshima Y, Ohtake J, Homma S, Kawamura H, et al. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci. 2017;108(10):1947–52.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sumida K, Ohno Y, Ohtake J, Kaneumi S, Kishikawa T, Takahashi N, et al. IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway. Sci Rep. 2015;15(1):13650.

Article  Google Scholar 

Ohtake J, Kaneumi S, Tanino M, Kishikawa T, Terada S, Sumida K, et al. Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells. J Allergy Clin Immunol. 2015;136(6):1690–4.

CAS  PubMed  Article  Google Scholar 

McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87–103.